SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-286800
Filing Date
2021-09-29
Accepted
2021-09-29 16:32:07
Documents
14
Period of Report
2021-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200196d8k.htm   iXBRL 8-K 37980
2 EX-4.1 d200196dex41.htm EX-4.1 847833
3 EX-10.1 d200196dex101.htm EX-10.1 1224650
  Complete submission text file 0001193125-21-286800.txt   2710729

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20210929.xsd EX-101.SCH 2880
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20210929_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20210929_pre.xml EX-101.PRE 10945
7 EXTRACTED XBRL INSTANCE DOCUMENT d200196d8k_htm.xml XML 3222
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 211292104
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences